CONGENITAL HEART DEFECT
Clinical trials for CONGENITAL HEART DEFECT explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HEART DEFECT trials appear
Sign up with your email to follow new studies for CONGENITAL HEART DEFECT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve implant offers hope for congenital heart patients
Disease control CompletedThis study tested a new valve called the Pulsta® Transcatheter Pulmonary Valve in 15 people with congenital heart disease and a faulty pulmonary valve. The valve is implanted through a catheter, avoiding open-heart surgery. Researchers checked if the valve improved blood flow and…
Matched conditions: CONGENITAL HEART DEFECT
Phase: NA • Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:31 UTC
-
Immune clues in rare lung disease explored
Knowledge-focused CompletedThis completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better…
Matched conditions: CONGENITAL HEART DEFECT
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Playtime prescription: new study tests if parent-led activity boosts health in kids with heart conditions
Knowledge-focused CompletedThis study tested whether a 6-month, parent-led physical activity program at home helps young children (ages 3 months to 6 years) born with heart defects get the recommended 180 minutes of daily activity after heart surgery or catheterization. The study enrolled 43 children and f…
Matched conditions: CONGENITAL HEART DEFECT
Phase: NA • Sponsor: Children's Hospital of Eastern Ontario • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC